Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Stock Information for Oncocyte Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Oncocyte Corporation

Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales
Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now
Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.